Case report: Therapeutic response of front-line cadonilimab plus chemotherapy on patient with advanced lung adenocarcinoma harboring STK11 genetic aberration

The STK11 gene mutation is a common genetic alteration in non-small cell lung cancer (NSCLC) and is significantly associated with poor responses to current immunotherapy regimens. Despite its prevalence, there is currently no established standard for front-line treatment in this subtype of NSCLC, un...

Повний опис

Бібліографічні деталі

Автори:	Du Feng, Huixin Jiang, Gengjia Chen, Wenhui Guan, Lin Yi, Yue Zhu, Yijia Li, Gengda Huang, Bin He, Junlong Tang, Yujie Tang, Jiyuan Zeng, Wensheng Zhou, Jiayu Shi, Zhanhong Xie, Ming Liu, Xiaohong Xie, Xinqing Lin, Chengzhi Zhou
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2024-12-01
Серія:	Frontiers in Immunology
Предмети:	STK11 mutation lung adenocarcinoma case report cadonilimab front-line therapy
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1485358/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!